Vulnerability · Published Aug 5, 2025 · Assigned by Roche

CVE-2025-7674navify Monitoring API input validation

High 7.1

In plain English

A high-severity improper input validation in navify Monitoring from Roche Diagnostics. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.3% (higher than 26% of all known vulnerabilities).

Severity (CVSS 4.0)7.1High

Exploit odds (30 days)0.3%top 74.3% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.

Affected products (as reported)

Vendor	Product	Versions
Roche Diagnostics	navify Monitoring	0 – before 1.08.00

Weakness: CWE-20 · Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/S:N/AU:Y/R:U/V:D/RE:M/U:Green

References

https://preview-owp.roche.com/content/dam/diagnostics/Blueprint/en/pdf/navify%20Monitoring%20-%20API%20Input%20Validation%20Vulnerability%20-%20Product%20Security%20Advisory.pdf vendor-advisory